{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-104015","form_type":"8-K","ticker":"IMNM","cik":"0001472012","company_name":"Immunome Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.056674+00:00","generated_at":"2026-05-17T19:10:07.958624+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Immunome Q2 net loss $43.4M; cash $268M; varegacestat Phase 3 topline data by end 2025","bullets":["Net loss of $43.4M for Q2 2025; cash, equivalents and securities $268M as of June 30.","R&D expenses $40.5M, G&A $10.0M; cash expected to fund operations into 2027.","Varegacestat Phase 3 RINGSIDE Part B topline data expected before end of 2025; EMA granted Orphan Drug Designation in July 2025.","IM-1021 Phase 1 trial dosing at third dose level; IM-3050 IND cleared April 2025, Phase 1 start expected by end 2025.","Three preclinical ADCs (IM-1617, IM-1340, IM-1335) undergoing IND-enabling work; additional undisclosed ADCs in discovery."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-104015","json":"https://secwatch.observer/filing/0000950170-25-104015.json","markdown":"https://secwatch.observer/filing/0000950170-25-104015.md","text":"https://secwatch.observer/filing/0000950170-25-104015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472012/000095017025104015/0000950170-25-104015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472012/000095017025104015/imnm-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:10:07.958624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}